2021 ESC/EACTS Guidelines for the management of valvular heart disease
Design
Clinical practice guidelines
Authors
Discussion
Loading...
Member takes
Implication
Guideline disclaimers flag potential conflicts with authorities; leaves open responsibility for clinical application in ambiguous cases.
Key Points
- Provide updated, evidence-based recommendations to assist healthcare professionals in diagnosing, managing, and treating valvular heart disease.
- Joint consensus guideline developed through comprehensive evaluation of available clinical and scientific evidence by the ESC and EACTS.
- Formulation of clinical recommendations addressing preventive, diagnostic, and interventional therapeutic strategies.
- Establishes evidence-based standards for diagnostic evaluation, pharmacotherapy, catheter-based interventions, and surgical procedures in valvular heart disease.
- Emphasizes that guideline recommendations should inform but not replace individualized clinical judgment, local regulatory requirements, and shared decision-making with patients.
PICO
P
Population
Valvular heart disease
Provides the 2021 ESC/EACTS clinical practice guidelines for the management of valvular heart disease.
Cite This Study
Beyersdorf et al. (2021) studied Valvular heart disease. The 2021 ESC/EACTS Guidelines provide updated recommendations for the management of valvular heart disease based on current scientific and medical evidence.